510(k) Report

510(k) · Cleared

Cleared

Powder Free Nitrile Examination Glove 2.8 Blue Color, Non-Sterile, and Tested for Use with Chemotherapy Drugs, Fentanyl Citrate, and Select Other Drugs

K233598510(k) TraditionalCleared Jan 26, 202478-day reviewClass I21 CFR 880.6250

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Anhui Intco Medical Products Co., Ltd. · LZA Polymer Patient Examination Glove

Cleared on Jan 26, 2024 as substantially equivalent to K223713 (Better Care Plastic Technology Co., Ltd., 2023) after a 78-day review. Its family tree reaches back 4 generations to 2019.

Decided
Jan 26, 2024
Review
78 days
Class
Class I
Product code
LZA
Recalls
None
Predicates
1

Its longest line of descent runs back 4 generations to K183287 (2019). No later device cites it as a predicate yet.

  1. Root · 4 generations backK183287 Powder Free Nitrile Patient Examination Glove, Blue Colored…Kossan International Sdn Bhd · 2019
  2. 3 generations backK192954 Power Free Nitrile Examination Gloves Tested for Use with…Comfort Rubber Gloves Industries Sdn. Bhd. · 2020
  3. 2 generations backK221269 Powder Free Nitrile Examination Gloves (Blue),Tested for Use with…Better Care Plastic Technology Co., Ltd. · 2022
  4. 1 generation backK223713 Powder Free Nitrile Examination Glove (Grey) Tested for Use with…Better Care Plastic Technology Co., Ltd. · 2023
  5. This deviceK233598 Powder Free Nitrile Examination Glove 2.8 Blue Color, Non-Sterile…Anhui Intco Medical Products Co., Ltd. · 2024
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K183287Powder Free Nitrile Patient Examination Glove, Blue Colored, Non-Sterile…Kossan International Sdn Bhd2019—
−3K192954Power Free Nitrile Examination Gloves Tested for Use with Chemotherapy Drugs…Comfort Rubber Gloves Industries Sdn. Bhd.2020—
−2K221269Powder Free Nitrile Examination Gloves (Blue),Tested for Use with Chemotherapy…Better Care Plastic Technology Co., Ltd.2022—
−1K223713Powder Free Nitrile Examination Glove (Grey) Tested for Use with Chemotherapy…Better Care Plastic Technology Co., Ltd.2023—
0 (this device)K233598Powder Free Nitrile Examination Glove 2.8 Blue Color, Non-Sterile, and Tested…Anhui Intco Medical Products Co., Ltd.2024—
FIG. 1 — Lineage of K233598, 2019–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LZA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LZA device

  1. #1 K192333 Blue Nitrile Examination Gloves Powder Freescore 71.0 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K223713Powder Free Nitrile Examination Glove (Grey) Tested for Use with Chemotherapy Drugs and…
Summary page 6
…Device Information: Better Care Plastic Technology Co., Ltd. Powder Free Nitrile Examination Glove (Grey) Tested for Use with Chemotherapy Drugs and Fentanyl Citrate (K223713) Product code LZA, LZC, QDO, OPJ. 4. Device Description: Powder Free Nitrile Examination Glove 2.8 Blue Color, Non-Sterile, a…
Better Care Plastic Technology Co., Ltd.2023—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 5 years and passes through 4 companies; a new generation was cleared every 1.2 years on median.
  • None of the 4 ancestors has a recall.

How does its category compare?

All LZA devices

LZA Polymer Patient Examination Glove: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.

FDA decisions per year · LZA

24in 2025

2007: 212008: 182009: 282010: 312011: 262012: 332013: 202014: 272015: 202016: 302017: 442018: 222019: 252020: 302021: 1392022: 1462023: 622024: 302025: 242026 (partial year): 15
2007high 146 (2022) · low 18 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LZA

110in 2025

2007: 95 days median2008: 97 days median2009: 112 days median2010: 97 days median2011: 122 days median2012: 110 days median2013: 130 days median2014: 197 days median2015: 112 days median2016: 171 days median2017: 124 days median2018: 178 days median2019: 212 days median2020: 101 days median2021: 111 days median2022: 111 days median2023: 92 days median2024: 89 days median2025: 110 days median2026 (partial year): 103 days median
2007high 212 (2019) · low 89 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LZA

3so far in 2026, the most since 2007

2015: 12016: 12026 (partial year): 3
2007high 3 (2026) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LZA

73in 2025

2007: 72008: 22009: 122010: 122011: 92012: 112013: 102014: 82015: 122016: 252017: 42018: 32019: 212020: 42021: 202022: 192023: 242024: 762025: 73
2007high 76 (2024) · low 2 (2008)2025

MAUDE reports naming product code LZA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007219507
2008189702
200928112012
20103197012
20112612209
201233110011
201320130010
20142719708
201520112112
201630171125
20174412404
20182217803
201925212021
20203010104
2021139111020
2022146111019
20236292024
20243089076
202524110073
2026151033—

What is it indicated for?

Powder Free Nitrile Examination Glove 2.8 Blue Color, Non-Sterile, and Tested for Use with Chemotherapy Drugs, Fentanyl Citrate, and Select Other Drugs is a disposable device intended for medical purposes that is worn on the examiner's hand or finger to prevent contamination between patient and examiner. These gloves were tested for use with Chemotherapy Drugs, Fentanyl Citrate, and Select Other Drugs as per ASTM D6978-05 (Reapproved 2019) Standard…

Read the full statement (338 words)

Powder Free Nitrile Examination Glove 2.8 Blue Color, Non-Sterile, and Tested for Use with Chemotherapy Drugs, Fentanyl Citrate, and Select Other Drugs is a disposable device intended for medical purposes that is worn on the examiner's hand or finger to prevent contamination between patient and examiner.

These gloves were tested for use with Chemotherapy Drugs, Fentanyl Citrate, and Select Other Drugs as per ASTM D6978-05 (Reapproved 2019) Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs.

Test Chemotherapy drug & Concentration Minimum Breakthrough Detection Times (Minutes)

Bendamustine HCI; 5 mg/ml >240

Bleomycin sulfate; 15 mg/ml >240

Busulfan ; 6 mg/ml >240

Carboplatin;10 mg/ml >240.

Carfilzomib; 2 mg/ml >240

Carmustine; 3.3 mg/ml 1.7

Cetuximab ; 2 mg/ml >240

Cisplatin; 1 mg/ml >240

Cladribine; 1 mg/ml >240

Cyclophosphamide; 20 mg/ml >240

Cytarabine ( Cytosine); 100 mg/ml >240

Cytovene (Ganciclovir); 10 mg/ml >240

Dacarbazine; 10 mg/ml >240

Daunorubicin HCL; 5 mg/ml >240

Decitabine; 5 mg/ml >240

Docetaxel; 20 mg/ml >240

Doxorubicin HCL; 2 mg/ml >240

Epirubicin HCL; 2 mg/ml >240

Etoposide; 20 mg/ml >240

Fludarabine Phosphate; 25 mg/ml >240

Fluorouracil; 50 mg/ml >240

Fulvestrant; 50 mg/ml >240

Gemcitabine HCI; 38 mg/ml >240

Idarubicin HCI; 1 mg/ml >240

Ifosfamide; 50 mg/ml >240

Irinotecan HCI ; 20 mg/ml >240

Mechlorethamine HCL; 1 mg/ml >240

Melphalan HCI; 5 mg/ml >240

Methotrexate ; 25 mg/ml >240

Mitomycin C; 0.5 mg/ml >240

Mitoxantrone HCI; 2 mg/ml >240

Oxaliplatin; 5 mg/ml >240

Pacilitaxel; 6 mg/ml >240

Pemetrexed; 25 mg/ml >240

Rituximab; 10 mg/ml >240

ThioTepa; 10 mg/ml 0

Topotecan HCL; 1 mg/ml >240

Trisonex; 1 mg/ml >240

Velcade (Bortezomib); 1 mg/ml >240

Vidaza (Azacytidine) ; 25 mg/ml >240

Vincrinstine Sulfate; 1 mg/ml >240

Vinorelbine Tartrate; 10 mg/ml >240

Zoledronic Acid; 0.8 mg/ml >240

Please note that the following drugs have extremely low permeation times: Carmustine (BCNU): 1.7 minutes and

Thiotepa:0 minute

Warning: Do not use with Carmustine and Thiotepa

Fentanyl Citrate & Other Drugs Minimum Breakthrough Detection Times

Fentanyl Citrate Injection(100 mcg/2ml) >240

Chloroquine; 50mg/ml >240

Cyclosporin A; 100mg/mi >240

Retrovir; 10 mg/ml >240

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K233598: Powder Free Nitrile Examination Glove 2.8 Blue Color, Non-Sterile, and Tested for Use with Chemotherapy Drugs, Fentanyl Citrate, and Select Other Drugs.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K233598

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026